KR890009890A - 하이드록시 피리미딘의 아실 유도체 - Google Patents
하이드록시 피리미딘의 아실 유도체 Download PDFInfo
- Publication number
- KR890009890A KR890009890A KR1019880015981A KR880015981A KR890009890A KR 890009890 A KR890009890 A KR 890009890A KR 1019880015981 A KR1019880015981 A KR 1019880015981A KR 880015981 A KR880015981 A KR 880015981A KR 890009890 A KR890009890 A KR 890009890A
- Authority
- KR
- South Korea
- Prior art keywords
- substituted
- dimethyl
- phenyl
- alkyl
- phenylalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (10)
- 일반식(Ⅰ)의 화합물, 이의 약제학적으로 허용되는 산부가염, 및 일반식(Ⅰ)에서 R5가 (C2-C3)알킬카복시인 경우, 이의 약제학적으로 허용되는 염기부가염.상기식에서, R1은 수소 또는 (C1-C15)알킬이고; R2는 수소, (C1-C15)알킬, 사이클로펜틸, 사이클로헥실, (C2-C15알케닐,페닐, 치환된 페닐, (C7-C20)페닐알킬, 또는 치환된 (C7-C20)페닐알킬이거나; R1및 R2가 이들의 결합된 질소원자와 함께는 하나의 (C1-C6)알킬, 페닐 또는 치환된 페닐,(C7-C20)페닐알킬,치환된 (C7-C20)페닐알킬, 푸틸, 티에틸, 하나의 (C1-C6)알킬에 의해 치환된 푸릴, 또는 하나의 (C1-C2)알킬에 의해 치환된 테에닐이며; R4는 수소,(C1-C6)알킬, 페닐, 치환된 페닐, (C7-C10)페닐알킬, 또는 치환된(C7-C10)페닐알킬이며; R6는 수소,(C1-C10)알킬, (C7-C10)알콕시, 페닐,(C7-C10)페닐알킬, 치환된 (C7-C20)페닐알킬, (C2-C3)알킬카복시, 또는 -NR6R7(여기에서, R6및 R7은 독립적으로, (C1-C10)알킬, 페닐, 치환된 페닐, (C7-C20)페닐알킬 및 치환된 (C7-C20)페닐알킬로 구성된 그룹에서 선택된다)이고; 상기의 치환된 페닐 및 치환된 피닐알킬상의 페닐 잔기는 플루오로, 플로로,(C1-C3)알킬,(C1-C3)알콕시 및 CF3로 구성된 그룹에서 선택된 잔기 하나 또는 두개에 의해 치환될수 있으며, 단, R1및 R2둘다 수소인 경우, R5는 메틸일 수 없다.
- 제1항에 있어서, R2가 수소, (C1-C15)알킬, 페닐, 치환된 페닐, (C7-C20)페닐알킬, 또는 치환된 (C7-C20)페닐알킬, (여기에서, 치환된 페닐 및 치환된 페닐알킬상의 페닐 잔기는 클로로 및 (C1-C3)알킬로 구성된 그룹으로부터 선택된 잔기 하나 또는 두개에 의해 치환되며);이고R2가 (C1-C6)알킬 또는 페닐기이거나,또는 플루오로, 클로로, 메틸, 에틸, 메톡시, 에톡시, 및 C2로 구성된 그룹으로부터 선택된 잔기 하나 또는2개에 의해 치환된 페닐이며;R4는 수소, (C1-C6)알킬, 또는 페닐기이거나, 메틸 및 에틸로 구성된 그룹으로부터 선택된 잔기 하나 또는 두개에 의해 치환된 페닐인 화합물.
- 제2항에 있어서, R1이 수소이고, R2가 수소가 아닌 화합물.
- 제1항에 있어서, R1이 수소이고, R2는 플루오로, 플로로, (C1-C3)알킬, (C1-C6)알콕시, 및 CF3로구성된 그룹으로부터 선택된 잔기 하나 또는 두개에 의해 페닐잔기가 치환될 수 있는 (C7-C12)페닐알킬인 화합물.
- 제1항에 있어서, R1이 수소이고, R2가 (C8-C9)알킬, (C9-C12)페닐알킬, (C10-C12)p-클로로페닐알킬 또는(C10-C12)P- 메틸페닐알킬이며, R3및 R4각각이 메틸이고, R5가 (C1-C6)-알킬 또는 (C1-C6)알콕시인 화합물.
- 제1항에 있어서, 5-아세톡시-4,6-디메틸-2-페닐헥실아미노피리미딘 및 4,6-디메틸-2-페닐헥실아미노-5-(에틸옥시포르밀)-옥시피리미딘으로 구성된 그룹으로부터 선택된 화합물 및 이의 산부가염.
- 제1항에 있어서, 5-벤조일옥시-4,6-디메틸-2-페닐헥실아미노피리미딘, 4,6-디메틸-2-페닐헥실아미노-5-O-톨루일옥시피리미딘, 5-카프로일옥시-4,6-디메틸-2-페닐헥실아미노피리미딘, 5-[옥소-(1-카복시-5-페닐펜탄)]-4,6-디메틸-2-페닐헥실아미노피리미딘, 4,6-디메틸-5-[(p-N,N-디에틸메틸아미노)]벤조일옥시-2-페닐헥실아미노피리미딘, 4,6-디메틸-2-페닐헥실아미노-5-석시노일옥시피리미딘, 4,6-디메틸-5-[(-모르폴리노메틸)]벤조일옥시-2-페닐헥실아미노피리미딘, 4,6-디메틸-2-페닐헥실아미노-5-프로파노일옥시피리미딘, 4,6-디메틸-2-페닐아미노-5-(2-티에노일)옥시피리미딘, 4,6-디메틸-2-페닐헥실아미노-5-(페닐옥시포르밀)옥시피리미딘, 4,6-디메틸-2-페닐헥실아미노-5-(이소부틸옥시프로밀)옥시피리미딘, 5-(N,N-디메틸아미노포르밀)옥시-4,6-디메틸-2-페닐헥실아미노피리미딘, 5-(N,N-디메틸아미노포르밀)옥시-4-이소프로필-6-메틸-2-페닐헥실아미노피리미딘, 4,6-디메틸-5-옥소(1-카복시-2,2-디메틸프로판)-2-페닐펜틸아미노피리미딘, 4,6-디메틸-2-페닐펜틸아미노-5-(이소부틸옥시포르밀)옥시피리미딘, 5-벤조일옥시-4,6-디메틸-2-페닐헥실아미노피리미딘 및 5-(N,N-디메틸아미노포르밀)옥시-4,6-디메틸-2-페닐펜틸아미노피리미딘으로 구성된 그룹으로부터 선택된 화합물 및 이의 산부가염.
- 폐질환, 천식, 알레르기성 질환 또는 염증성 질환중 하나 이상의 질환을 치료하기에 유용한 양의 제1 내지 7항중 어느 한 항에 따라 화합물 및 약제학적으로 허용되는 담체를 함유함을 특징으로 하는, 상기의 질환치료용 약제학적 조성물.
- 폐질환, 천식, 알레르기성 질환,건선, 또는 염증성 질환의 치료를 필요로 하는 포유동물에 제1내지7항중 어느 한 항에 따른 화합물을 투여함을 특징으로 하는 상기 질환의 치료방법.
- 류코트리엔의 합성억제를 필요로 하는 포유동물에 유효량의 제1내지 7항중 어느 한 항에 따른 화합물을 투여함을 특징으로 하여, 포유동물의 류코트리엔 합성을 억제하는 방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1987/003171 WO1989005295A1 (en) | 1987-12-02 | 1987-12-02 | Acyl derivatives of hydroxypyrimidines |
USPCT/US87/03171 | 1987-12-02 | ||
USPCT/8703171 | 1987-12-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR890009890A true KR890009890A (ko) | 1989-08-04 |
KR910000415B1 KR910000415B1 (ko) | 1991-01-25 |
Family
ID=22202696
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019880015981A KR910000415B1 (ko) | 1987-12-02 | 1988-12-01 | 하이드록시 피리미딘의 아실 유도체 |
Country Status (26)
Country | Link |
---|---|
EP (1) | EP0319170B1 (ko) |
JP (1) | JPH0725740B2 (ko) |
KR (1) | KR910000415B1 (ko) |
CN (1) | CN1033379A (ko) |
AT (1) | ATE86983T1 (ko) |
AU (1) | AU609547B2 (ko) |
CA (1) | CA1336516C (ko) |
DD (1) | DD277275A5 (ko) |
DE (1) | DE3879410T2 (ko) |
DK (1) | DK671188A (ko) |
EG (1) | EG19003A (ko) |
ES (1) | ES2053769T3 (ko) |
FI (1) | FI893648A0 (ko) |
HU (1) | HU206203B (ko) |
IE (1) | IE63456B1 (ko) |
IL (1) | IL88512A0 (ko) |
MX (1) | MX14001A (ko) |
MY (1) | MY103499A (ko) |
NO (1) | NO893105L (ko) |
NZ (1) | NZ227163A (ko) |
PL (1) | PL158165B1 (ko) |
PT (1) | PT89124B (ko) |
RU (1) | RU2036909C1 (ko) |
WO (1) | WO1989005295A1 (ko) |
YU (1) | YU47013B (ko) |
ZA (1) | ZA888969B (ko) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0449883B1 (en) * | 1988-12-21 | 1996-01-31 | Massachusetts Institute Of Technology | A method for laser induced fluorescence of tissue |
US5270319A (en) * | 1991-09-09 | 1993-12-14 | Warner-Lambert Company | 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents |
US5220025A (en) * | 1992-02-24 | 1993-06-15 | Warner-Lambert Company | 2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents |
US5196431A (en) * | 1992-02-24 | 1993-03-23 | Warner-Lambert Company | 2-substituted amino-4, 6-di-tertiary-buthyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents |
AU2003232650A1 (en) * | 2003-05-06 | 2004-11-26 | Il Yang Pharm Co., Ltd. | N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof |
KR20170057191A (ko) * | 2017-05-04 | 2017-05-24 | 김점식 | 유압을 이용한 전기 자동차 구동장치 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4554276A (en) * | 1983-10-03 | 1985-11-19 | Pfizer Inc. | 2-Amino-5-hydroxy-4-methylpyrimidine derivatives |
US4711888A (en) * | 1985-07-24 | 1987-12-08 | Pfizer Inc. | Hydroxy and alkoxy pyrimidines |
-
1987
- 1987-12-02 HU HU894552A patent/HU206203B/hu not_active IP Right Cessation
- 1987-12-02 MX MX1400188A patent/MX14001A/es unknown
- 1987-12-02 WO PCT/US1987/003171 patent/WO1989005295A1/en active Application Filing
-
1988
- 1988-11-17 ES ES88310862T patent/ES2053769T3/es not_active Expired - Lifetime
- 1988-11-17 EP EP88310862A patent/EP0319170B1/en not_active Expired - Lifetime
- 1988-11-17 DE DE8888310862T patent/DE3879410T2/de not_active Expired - Fee Related
- 1988-11-17 AT AT88310862T patent/ATE86983T1/de active
- 1988-11-28 IL IL88512A patent/IL88512A0/xx not_active IP Right Cessation
- 1988-11-28 MY MYPI88001366A patent/MY103499A/en unknown
- 1988-11-30 PT PT89124A patent/PT89124B/pt not_active IP Right Cessation
- 1988-11-30 CA CA000584529A patent/CA1336516C/en not_active Expired - Fee Related
- 1988-11-30 ZA ZA888969A patent/ZA888969B/xx unknown
- 1988-12-01 IE IE359888A patent/IE63456B1/en not_active IP Right Cessation
- 1988-12-01 NZ NZ227163A patent/NZ227163A/en unknown
- 1988-12-01 DK DK671188A patent/DK671188A/da not_active Application Discontinuation
- 1988-12-01 AU AU26470/88A patent/AU609547B2/en not_active Ceased
- 1988-12-01 KR KR1019880015981A patent/KR910000415B1/ko not_active IP Right Cessation
- 1988-12-01 CN CN88108324A patent/CN1033379A/zh active Pending
- 1988-12-01 PL PL1988276122A patent/PL158165B1/pl unknown
- 1988-12-01 DD DD88322482A patent/DD277275A5/de not_active IP Right Cessation
- 1988-12-01 YU YU217988A patent/YU47013B/sh unknown
- 1988-12-01 EG EG61388A patent/EG19003A/xx active
- 1988-12-02 JP JP30589388A patent/JPH0725740B2/ja not_active Expired - Lifetime
-
1989
- 1989-08-01 NO NO89893105A patent/NO893105L/no unknown
- 1989-08-01 FI FI893648A patent/FI893648A0/fi not_active Application Discontinuation
-
1992
- 1992-03-19 RU SU925011792A patent/RU2036909C1/ru active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR920014805A (ko) | 퀴나졸리논 화합물, 그의 제약학적 조성물 및 그의 제조방법 | |
KR930700482A (ko) | 신경보호성 안돌론 및 관련 유도체 | |
KR970704702A (ko) | 치환된 피리미딘 화합물 및 그의 용도(Substituted Pyrimidine Compounds and Their Use) | |
NO159795C (no) | Fremgangsmaate for fremstilling av 2-penemforbindelser. | |
EA200100755A1 (ru) | 4-оксо-1,4-дигидро-3-хинолинкарбоксамиды как антивирусные агенты | |
ATE120955T1 (de) | Benzyliden-malononitril-derivate zur hemmung von proliferativen prozessen in säugetierzellen. | |
ITMI912237A1 (it) | Derivati di geneserina, loro preparazione e composizioni farmaceutiche che li contengono | |
DE3769404D1 (de) | Phenolische benzthiazolderivate und ihre verwendung als korrosionsinhibitoren. | |
CA2099867A1 (en) | 2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents | |
KR880000413A (ko) | 항알레르기 및 소염 제제와 그의 제조방법 | |
KR890009890A (ko) | 하이드록시 피리미딘의 아실 유도체 | |
MX9202782A (es) | Compuesto triciclos y composiciones farmaceuticas que lo contienen. | |
KR880012586A (ko) | 새로운 피리딜 및 피리미딜 유도체 | |
KR960706476A (ko) | 인터류킨-1 활성 억제제로서의 신규한 벤젠설포닐아민 유도체(Novel benzen-esulfonylimine derivatives as inhibitors of lL-1 action) | |
KR880007494A (ko) | 5-아릴-3h-1,2,4-트리아졸-3-온 및 진경제로서의 그들의 용도 | |
ATE149494T1 (de) | Benzopyranderivate und verfahren zu deren herstellung | |
ATE140224T1 (de) | Unverbrückte bis-aryl-carbinol-derivate, zusammensetzungen und ihre verwendung | |
DE69130266D1 (de) | Optisch wirksame Alkylendioxybenzolderivate und ihre Verwendung als Arzneimittel | |
ATE18761T1 (de) | Carbamoyloxybenzhydrol-derivate, ihre herstellung und ihre pharmazeutische zusammensetzungen. | |
ATE139441T1 (de) | Verwendung von 2-iminothiazolidin-4-onderivaten als neuartige arzneimittelwirkstoffe | |
KR890008121A (ko) | 로다닌 유도체 및 약제학적 조성물 | |
KR920012100A (ko) | 비스포스폰산 유도체, 이의 제조 및 용도 | |
DK148058C (da) | Analogifremgangsmaade til fremstilling af thiazolderivater eller syreadditionssalte deraf | |
SE8703494L (sv) | Mellanprodukter anvendbara vid framstellning av 2-tiofen-ettiksyraderivat | |
ATE144900T1 (de) | Verwendung von xanthinderivaten gegen magengeschwüre |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 19961113 Year of fee payment: 7 |
|
LAPS | Lapse due to unpaid annual fee |